Aoyagi Y - Search Results

1

Longitudinal increase in albumin-bilirubin score is associated with non-malignancy-related mortality and quality of life in patients with liver cirrhosis.

Sakamaki A, Takamura M, Sakai N, Watanabe Y, Arao Y, Kimura N, Setsu T, Abe H, Yokoo T, Kamimura H, Tsubata S, Waguri N, Ishikawa T, Kawai H, Sugitani S, Sato T, Funakoshi K, Watanabe M, Igarashi K, Kamimura K, Tsuchiya A, Aoyagi Y, Terai S. Sakamaki A, et al. Among authors: aoyagi y. PLoS One. 2022 Feb 3;17(2):e0263464. doi: 10.1371/journal.pone.0263464. eCollection 2022. PLoS One. 2022. PMID: 35113969 Free PMC article.

2

A lectin-based monoclonal enzyme immunoassay to distinguish fucosylated and non-fucosylated alpha-fetoprotein molecular variants.

Suzuki Y, Aoyagi Y, Muramatsu M, Igarashi K, Saito A, Oguro M, Isemura M, Asakura H. Suzuki Y, et al. Among authors: aoyagi y. Ann Clin Biochem. 1990 Mar;27 ( Pt 2):121-8. doi: 10.1177/000456329002700206. Ann Clin Biochem. 1990. PMID: 1691608

3

The fucosylation index of alpha-fetoprotein and its usefulness in the early diagnosis of hepatocellular carcinoma.

Aoyagi Y, Suzuki Y, Isemura M, Nomoto M, Sekine C, Igarashi K, Ichida F. Aoyagi Y, et al. Cancer. 1988 Feb 15;61(4):769-74. doi: 10.1002/1097-0142(19880215)61:4<769::aid-cncr2820610422>3.0.co;2-m. Cancer. 1988. PMID: 2448024

4

Sequence analysis of the proximal promoter region of the human alpha-fetoprotein gene in hepatocellular carcinoma.

Igarashi K, Aoyagi Y, Ohkoshi S, Yokota T, Mori S, Suda T, Kamimura T, Asakura H. Igarashi K, et al. Among authors: aoyagi y. Cancer Lett. 1994 Jan 30;76(2-3):93-9. doi: 10.1016/0304-3835(94)90383-2. Cancer Lett. 1994. PMID: 7511984

5

Fucosylation index of alpha-fetoprotein, a possible aid in the early recognition of hepatocellular carcinoma in patients with cirrhosis.

Aoyagi Y, Saitoh A, Suzuki Y, Igarashi K, Oguro M, Yokota T, Mori S, Suda T, Isemura M, Asakura H. Aoyagi Y, et al. Hepatology. 1993 Jan;17(1):50-2. Hepatology. 1993. PMID: 7678576

6

Highly enhanced fucosylation of alpha-fetoprotein in patients with germ cell tumor.

Aoyagi Y, Suzuki Y, Igarashi K, Yokota T, Mori S, Suda T, Naitoh A, Isemura M, Asakura H. Aoyagi Y, et al. Cancer. 1993 Jul 15;72(2):615-8. doi: 10.1002/1097-0142(19930715)72:2<615::aid-cncr2820720246>3.0.co;2-t. Cancer. 1993. PMID: 7686444

7

The fucosylation index of alpha-fetoprotein as a possible prognostic indicator for patients with hepatocellular carcinoma.

Aoyagi Y, Isokawa O, Suda T, Watanabe M, Suzuki Y, Asakura H. Aoyagi Y, et al. Cancer. 1998 Nov 15;83(10):2076-82. Cancer. 1998. PMID: 9827711

8

Quantitative evaluation of genomic instability as a possible predictor for development of hepatocellular carcinoma: comparison of loss of heterozygosity and replication error.

Kawai H, Suda T, Aoyagi Y, Isokawa O, Mita Y, Waguri N, Kuroiwa T, Igarashi M, Tsukada K, Mori S, Shimizu T, Suzuki Y, Abe Y, Takahashi T, Nomoto M, Asakura H. Kawai H, et al. Among authors: aoyagi y. Hepatology. 2000 Jun;31(6):1246-50. doi: 10.1053/jhep.2000.7298. Hepatology. 2000. PMID: 10827149

9

Diagnosis of pancreatic adenocarcinoma by detection of human telomerase reverse transcriptase messenger RNA in pancreatic juice with sample qualification.

Seki K, Suda T, Aoyagi Y, Sugawara S, Natsui M, Motoyama H, Shirai Y, Sekine T, Kawai H, Mita Y, Waguri N, Kuroiwa T, Igarashi M, Asakura H. Seki K, et al. Among authors: aoyagi y. Clin Cancer Res. 2001 Jul;7(7):1976-81. Clin Cancer Res. 2001. PMID: 11448913

10

[Loss of heterozygosity in hepatocarcinogenesis].

Suda T, Kawai H, Aoyagi Y. Suda T, et al. Among authors: aoyagi y. Nihon Rinsho. 2001 Oct;59 Suppl 6:129-33. Nihon Rinsho. 2001. PMID: 11761927 Review. Japanese. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

872 results

Search Page